Clinical Trial Update: UCMSCs as Front-line Approach of Treatment for Patients With aGVHD [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting completion of a Phase 1/2 study evaluating umbilical cord-derived mesenchymal stem cells as first-line therapy for acute graft-v…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• UCMSCs (umbilical cord-derived mesenchymal stem cells) (umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: Cytopeutics Sdn. Bhd. | Conditions: Acute-graft-versus-host Disease | Phase 1, Phase 2 | Status: COMPLETED